User profiles for P Sokoloff

Pierre sokoloff

Biodol Therapeutics
Verified email at biodol.eu
Cited by 24159

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

P Sokoloff, J Diaz, BL Foll, O Guillin… - CNS & Neurological …, 2006 - ingentaconnect.com
The role of the D3 receptor has remained largely elusive before the development of
selective research tools, such as selective radioligands, antibodies, various highly specific …

Novel dopamine receptors half a decade later

P Sokoloff, JC Schwartz - Trends in pharmacological sciences, 1995 - cell.com
… Pierre Sokoloff and Jean-Charles Schwarlz … Substance P and neurotensin of nucleus
accumbens … Substance P and neurotensin neurones …

The dopamine D3 receptor, a quarter century later

P Sokoloff, B Le Foll - European Journal of Neuroscience, 2017 - Wiley Online Library
This review updates the existing knowledge suggesting a role for the D3 receptor in schizophrenia
and drug addiction. The D3 receptor is expressed in brain regions controlling reward, …

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

P Sokoloff, B Giros, MP Martres, ML Bouthenet… - Nature, 1990 - nature.com
A dopamine receptor has been characterized which differs in its pharmacology and
signalling system from the D 1 or D 2 receptor and represents both an autoreceptor and a …

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA

ML Bouthenet, E Souil, MP Martres, P Sokoloff, B Giros… - Brain research, 1991 - Elsevier
The messenger RNA (mRNA) of the recently characterized D 3 dopamine receptor was
visualized on rat brain sections using in situ hybridization with a 32 P-labeled ribonucleic acid …

Alternative splicing directs the expression of two D2 dopamine receptor isoforms

B Giros, P Sokoloff, MP Martres, JF Riou, LJ Emorine… - Nature, 1989 - nature.com
DOPAMINE receptors are classified into D l and D 2 subtypes on the basis of their
pharmacological properties and the intracellular responses they mediate 1 . The cerebral D 2 …

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H] hydroxy-N, N-di-n-propyl-2-aminotetralin.

…, JL Morgat, JC Schwartz, P Sokoloff - Proceedings of the …, 1992 - National Acad Sciences
We have identified 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin ([3H]7-OH-DPAT) as a
selective probe for the recently cloned dopamine D3 receptor and used it to assess the …

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

…, J Diaz, P Carroll, N Griffon, JC Schwartz, P Sokoloff - Nature, 2001 - nature.com
… In wild-type BDNF +/+ mice, D 3 receptor binding and mRNA in AccSh increased sharply
from postnatal (P) days P9–P14 to P17–P23, whereas in homozygous BDNF -/- mice, D 3 …

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

…, CG Wermuth, JC Schwartz, BJ Everitt, P Sokoloff - Nature, 1999 - nature.com
Environmental stimuli that are reliably associated with the effects of many abused drugs,
especially stimulants such as cocaine, can produce craving and relapse in abstinent human …

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain

…, N Griffon, MP Martres, JC Schwartz, P Sokoloff - Neuroscience, 1995 - Elsevier
We have established the cellular distribution of the dopamine D 3 receptor using tritiated 7-hydroxy-NN-di-n-propyl-2-aminotetralin
and a complementary RNA probe to visualize …